Rapalogix Health
New York, US · Founded 2023 · Delaware corporation · 28 employees on LinkedIn · 3 known investors
Find your way into Rapalogix Health
1,303 people in our graph share verified history with the Rapalogix Health team — schools, employers, funds. One of them is your warm intro.
Laura Buhlerunlockedknows Juliette Han · together at McKinsey & Company (overlapped)
×9knows the team · via McKinsey & Company
knows the team · via Columbia Business School
knows the team · via Harvard Medical School
Founders & leadership
JH
Juliette HaninDirector Board of DirectorsJuliette Han is a neuroscientist with a PhD from Harvard and master's and bachelor's degrees from UCLA who has held leadership roles in biotech and finance, including Chief Financial Officer and Chief Operating Officer at Cambrian Bio, Chief of Staff at McKinsey New Ventures and Two Sigma Private Investments, and Chief Operating Officer of People at Citadel.
RM
Rahul MehtainCo-Founder and CEO
BS
Brent SaundersExecutive
Board
JP
James PeyerBoard director
DN
David NicholsonBoard director
JM
Joan MannickBoard director
DD
Doris DayBoard director
Investors · 3
Also in the syndicate · 3
GordonMD Global Investments LPleadGordonMD Global Investments® LPleadWoodline Partnerslead
Reported raises · per SEC filings
Form D private placements$28.2M disclosed across 2 rounds · 2023–2026
▶$19.1MraisedJun 2026 · 28 investors · BiotechnologyRule 506(b)
▶$19.1MraisedJun 2026 · 28 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rahul MehtaExecutive Officer
- Juliette HanDirector
- Neetu DhaliwalDirector
- Brent SaundersDirector
- Doris DayDirector
- James PeyerDirector
- David NicholsonDirector
- Craig GordonDirector
- Offering amount
- $25M
- Amount sold
- $19.1M
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$9.1MraisedJun 2025 · 24 investors · BiotechnologyRule 506(b)
▶$9.1MraisedJun 2025 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David NicholsonDirector
- James PeyerDirector
- Juliette HanExecutive Officer, Director
- Rahul MehtaExecutive Officer
- Joan MannickDirector
- Doris DayDirector
- Brent SaundersExecutive Officer, Director
- Offering amount
- $13.5M
- Amount sold
- $9.1M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Rapalogix Health went on to found or lead other companies.
In the news
Rapalogix Secures $20M for Skincare Pipelineallsci.com · Jun 2026
Rapalogix Health Closes $20 Million Series A Financing to Accelerate Re-Q Health Expansion and Advance Prescription Therapeutics Pipeline - BioSpacebiospace.com · Jun 2026Rapalogix Health Raises $20 Million in Series A Financing to Redefine the Future of Longevity-Based Skin Health - BioSpacebiospace.com · Jun 2026Frequently asked questions
- How much funding has Rapalogix Health raised?
- Rapalogix Health has disclosed $28.2M raised across 2 rounds.
- Where is Rapalogix Health headquartered?
- Rapalogix Health is headquartered in New York, US.